← Back to directory

Hilde Lavreysen

Researcher Next ID · RN-039444

Researcher · Biochemistry, Genetics and Molecular Biology

Janssen (Belgium)

Beerse, Belgium

Accepting doctoral researchersFunding unknown
Works count
1,262
Citation count
2,684
H-index
28
i10-index
54

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Neuroscience
Neuroscience and Neuropharmacology Research
Receptor Mechanisms and Signaling
Electroconvulsive Therapy Studies
Pharmacological Effects and Toxicity Studies
Schizophrenia research and treatment

Publications

  • Molecular Switches of Allosteric Modulation of the Metabotropic Glutamate 2 Receptor

    Structure · 2017 · 10.1016/j.str.2017.05.021

  • Discovery of 8-Trifluoromethyl-3-cyclopropylmethyl-7-[(4-(2,4-difluorophenyl)-1-piperazinyl)methyl]-1,2,4-triazolo[4,3-a]pyridine (JNJ-46356479), a Selective and Orally Bioavailable mGlu2 Receptor Positive Allosteric Modulator (PAM)

    Journal of Medicinal Chemistry · 2016 · 10.1021/acs.jmedchem.6b00913

  • Molecular mechanism of positive allosteric modulation of the metabotropic glutamate receptor 2 by JNJ‐46281222

    British Journal of Pharmacology · 2015 · 10.1111/bph.13390

  • Discovery of VU0409551/JNJ-46778212: An mGlu5 Positive Allosteric Modulator Clinical Candidate Targeting Schizophrenia

    ACS Medicinal Chemistry Letters · 2015 · 10.1021/acsmedchemlett.5b00181

  • Preclinical evaluation of the antipsychotic potential of the mGlu2‐positive allosteric modulator JNJ‐40411813

    Pharmacology Research & Perspectives · 2015 · 10.1002/prp2.97

  • Biased mGlu 5 -Positive Allosteric Modulators Provide In Vivo Efficacy without Potentiating mGlu 5 Modulation of NMDAR Currents

    Neuron · 2015 · 10.1016/j.neuron.2015.03.063

  • Discovery of 1-Butyl-3-chloro-4-(4-phenyl-1-piperidinyl)-(1 H )-pyridone (JNJ-40411813): A Novel Positive Allosteric Modulator of the Metabotropic Glutamate 2 Receptor

    Journal of Medicinal Chemistry · 2014 · 10.1021/jm500496m

  • Pharmacological and pharmacokinetic properties of JNJ‐40411813, a positive allosteric modulator of the mGlu2 receptor

    Pharmacology Research & Perspectives · 2014 · 10.1002/prp2.96

  • Pharmacological Characterization of JNJ-40068782, a New Potent, Selective, and Systemically Active Positive Allosteric Modulator of the mGlu2 Receptor and Its Radioligand [3H]JNJ-40068782

    Journal of Pharmacology and Experimental Therapeutics · 2013 · 10.1124/jpet.113.204990

  • N-Aryl Piperazine Metabotropic Glutamate Receptor 5 Positive Allosteric Modulators Possess Efficacy in Preclinical Models of NMDA Hypofunction and Cognitive Enhancement

    Journal of Pharmacology and Experimental Therapeutics · 2013 · 10.1124/jpet.113.206623

  • Synthesis, Evaluation, and Radiolabeling of New Potent Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 2 as Potential Tracers for Positron Emission Tomography Imaging

    Journal of Medicinal Chemistry · 2012 · 10.1021/jm300912k

  • Pharmacology of JNJ-37822681, a Specific and Fast-Dissociating D2 Antagonist for the Treatment of Schizophrenia

    Journal of Pharmacology and Experimental Therapeutics · 2012 · 10.1124/jpet.111.190702

  • Discovery of 3-Cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl[1,2,4]triazolo[4,3-a]pyridine (JNJ-42153605): A Positive Allosteric Modulator of the Metabotropic Glutamate 2 Receptor

    Journal of Medicinal Chemistry · 2012 · 10.1021/jm3010724

  • Imidazo[1,2-a]pyridines: Orally Active Positive Allosteric Modulators of the Metabotropic Glutamate 2 Receptor

    Journal of Medicinal Chemistry · 2012 · 10.1021/jm201561r

  • Functional Impact of Allosteric Agonist Activity of Selective Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 in Regulating Central Nervous System Function

    Molecular Pharmacology · 2011 · 10.1124/mol.111.075184

  • Acetylcholinesterase and Cognitive Enhancement

    Journal · 2010 · 10.1007/978-3-540-68706-1_164

  • Summary of Product Characteristics

    Journal · 2010 · 10.1007/978-3-540-68706-1_698

  • Summary of Product Characteristics

    Journal · 2010 · 10.1007/978-3-540-68706-1_698

  • Characterization of 2-[[4-Fluoro-3-(trifluoromethyl)phenyl]amino]-4-(4-pyridinyl)-5-thiazolemethanol (JNJ-1930942), a Novel Positive Allosteric Modulator of the α7 Nicotinic Acetylcholine Receptor

    Journal of Pharmacology and Experimental Therapeutics · 2010 · 10.1124/jpet.110.173245

  • Addiction Research Center Inventory

    Journal · 2010 · 10.1007/978-3-540-68706-1_938

  • Attention Deficit and Disruptive Behavior Disorders

    Journal · 2010 · 10.1007/978-3-540-68706-1_338

  • Attention Deficit and Disruptive Behavior Disorders

    Journal · 2010 · 10.1007/978-3-540-68706-1_338

  • Attention Deficit Hyperactivity Disorder

    Journal · 2010 · 10.1007/978-3-540-68706-1_488

  • Attention Deficit Hyperactivity Disorder

    Journal · 2010 · 10.1007/978-3-540-68706-1_488

  • Acetylcholinesterase and Cognitive Enhancement

    Journal · 2010 · 10.1007/978-3-540-68706-1_164

  • Progress in the Developement of Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 2

    Current Medicinal Chemistry · 2010 · 10.2174/092986711793979706

  • Metabotropic Glutamate Receptors: Their Therapeutic Potential in Anxiety

    Current topics in behavioral neurosciences · 2010 · 10.1007/7854_2010_36

  • Signal Detection Theory

    Journal · 2010 · 10.1007/978-3-540-68706-1_848

  • Somatostatin Receptors

    Journal · 2010 · 10.1007/978-3-540-68706-1_1633

  • Single Photon Emission Computed Tomography

    Journal · 2010 · 10.1007/978-3-540-68706-1_3573

  • Refractory Schizophrenia

    Journal · 2010 · 10.1007/978-3-540-68706-1_4504

  • Alcohol Withdrawal Syndrome

    Journal · 2010 · 10.1007/978-3-540-68706-1_448

  • Alcohol Withdrawal Syndrome

    Journal · 2010 · 10.1007/978-3-540-68706-1_448

  • Receptors: Binding Assays

    Journal · 2010 · 10.1007/978-3-540-68706-1_207

  • Reactive Oxygen Species

    Journal · 2010 · 10.1007/978-3-540-68706-1_1391

  • Activities of Daily Living

    Journal · 2010 · 10.1007/978-3-540-68706-1_1173

  • Activities of Daily Living

    Journal · 2010 · 10.1007/978-3-540-68706-1_1173

  • Atypical Antipsychotic Drugs

    Journal · 2010 · 10.1007/978-3-540-68706-1_468

  • Atypical Antipsychotic Drugs

    Journal · 2010 · 10.1007/978-3-540-68706-1_468

  • Addiction Research Center Inventory

    Journal · 2010 · 10.1007/978-3-540-68706-1_938

  • Scaffold hopping from pyridones to imidazo[1,2-a]pyridines. New positive allosteric modulators of metabotropic glutamate 2 receptor

    Bioorganic & Medicinal Chemistry Letters · 2009 · 10.1016/j.bmcl.2009.11.008

  • Therapeutic Potential of Group III Metabotropic Glutamate Receptors

    Current Medicinal Chemistry · 2008 · 10.2174/092986708783885246

  • Metabotropic glutamate 1 receptor distribution and occupancy in the rat brain: a quantitative autoradiographic study using [3H]R214127

    Neuropharmacology · 2004 · 10.1016/j.neuropharm.2003.11.014

  • Effects of mGlu1 receptor blockade on anxiety-related behaviour in the rat lick suppression test

    Psychopharmacology · 2004 · 10.1007/s00213-004-2056-7

  • JNJ16259685, a highly potent, selective and systemically active mGlu1 receptor antagonist

    Neuropharmacology · 2004 · 10.1016/j.neuropharm.2004.08.007

  • [3H]R214127: A Novel High-Affinity Radioligand for the mGlu1 Receptor Reveals a Common Binding Site Shared by Multiple Allosteric Antagonists

    Molecular Pharmacology · 2003 · 10.1124/mol.63.5.1082

Current projects

    No projects listed.